Boston Scientific Corporation is an American medical device manufacturer. The company offers solutions for the following medical specialties: electrophysiology, gastroenterology, vascular surgery, gynecology, interventional cardiology, interventional radiology, female pelvic medicine, neurological surgery, orthopedic surgery, pulmology, pain medicine, structural heart, urology.
Revenue for Boston Scientific (BSX)
Revenue in 2023 (TTM): $14.24 B
According to Boston Scientific's latest financial reports the company's current revenue (TTM) is $14.24 B. In 2022 the company made a revenue of $12.68 B an increase over the years 2021 revenue that were of $11.88 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Boston Scientific from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $14.24 B | 12.29% |
| 2022 | $12.68 B | 6.68% |
| 2021 | $11.88 B | 19.91% |
| 2020 | $9.91 B | -7.65% |
| 2019 | $10.73 B | 9.28% |
| 2018 | $9.82 B | 8.58% |
| 2017 | $9.04 B | 7.88% |
| 2016 | $8.38 B | 12.16% |
| 2015 | $7.47 B | 1.31% |
| 2014 | $7.38 B | 3.32% |
| 2013 | $7.14 B | -1.48% |
| 2012 | $7.25 B | -4.88% |
| 2011 | $7.62 B | -2.36% |
| 2010 | $7.80 B | -4.67% |
| 2009 | $8.18 B | 1.71% |
| 2008 | $8.05 B | -3.69% |
| 2007 | $8.35 B | 6.87% |
| 2006 | $7.82 B | 24.48% |
| 2005 | $6.28 B | 11.72% |
| 2004 | $5.62 B | 61.8% |
| 2003 | $3.47 B | 19.08% |
| 2002 | $2.91 B | 9.2% |
| 2001 | $2.67 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | $32.32 B | 126.97% | 🇮🇪 Ireland |
 Edwards Lifesciences EW | $6.00 B | -57.83% | 🇺🇸 USA |
 Stryker Corporation SYK | $20.49 B | 43.95% | 🇺🇸 USA |
 Teleflex TFX | $2.97 B | -79.11% | 🇺🇸 USA |
 Merit Medical MMSI | $1.25 B | -91.17% | 🇺🇸 USA |
 AngioDynamics ANGO | $0.32 B | -97.72% | 🇺🇸 USA |
 CONMED CNMD | $1.24 B | -91.26% | 🇺🇸 USA |